Text Size

Cost-Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany

Lazzaro, C.; van Steen, C.; Billeit, S.; Frauenknecht, H.; Kallen, C.; Pfennigsdorf, S.; Thelen, U.; Angelillo, L.


  • 2022
  • Clinical Ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Affiliations

    Health Economist and Research Director, Studio di Economia Sanitaria, Milan, Italy; Santen GmbH, München, Germany; Private Practicing Ophthalmologist, Lübeck, Germany; Private Practicing Ophthalmologist, Treuchtlingen, Germany; Private Practicing Ophthalmologist, Krefeld, Germany; Private Practicing Ophthalmologist, Polch, Germany; Private Practicing Ophthalmologist, Münster, Germany; University Hospital Muenster, Department of Ophthalmology, Münster, Germany

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group


Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.


Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022